2017
DOI: 10.1055/s-0037-1604089 View full text |Buy / Rent full text
|
|

Abstract: Despite neurosurgical treatment, a subarachnoid hemorrhage (SAH) can cause a debilitating stroke. The case fatality rate ranges from 27 to 44%, and many survivors are left permanently disabled; therefore, the need for improved treatment is obvious. Furthermore, subdural hemorrhages (SDHs) have a cumulative recurrence rate of 14% in the first year and are potentially fatal. The aim of this systematic review is to assess and discuss the evidence for the role of tranexamic acid (TXA) in treatment of SAH and SDH. … Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
1
1
1
3
20
0
2

Year Published

2017
2017
2020
2020

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

3
20
0
2
Order By: Relevance
“…Bei über 30 % der Patienten besteht zudem die Indikation für eine thrombozytenfunktionshemmende Therapie (TFH) oder eine Antikoagulation [13]. [34]. Für den weiteren stationären Verlauf kann sich das generelle Management an Empfehlungen für den ischämischen Schlaganfälle orientieren, insbesondere die Vermeidung von Fieber sowie Hyperglykämien scheint das Outcome zu verbessern [35,36].…”
Section: Antithrombotisches Managementunclassified
Create an account to read the remaining citation statements from this report. You will also get access to:
  • Search over 1.2b+ citation statments to see what is being said about any topic in the research literature
  • Advanced Search to find publications that support or contrast your research
  • Citation reports and visualizations to easily see what publications are saying about each other
  • Browser extension to see Smart Citations wherever you read research
  • Dashboards to evaluate and keep track of groups of publications
  • Alerts to stay on top of citations as they happen
  • Automated reference checks to make sure you are citing reliable research in your manuscripts
  • 7 day free preview of our premium features.

Trusted by researchers and organizations around the world

Over 130,000 students researchers, and industry experts at use scite

See what students are saying

rupbmjkragerfmgwileyiopcupepmcmbcthiemesagefrontiersapsiucrarxivemeralduhksmucshluniversity-of-gavle
“…Bei über 30 % der Patienten besteht zudem die Indikation für eine thrombozytenfunktionshemmende Therapie (TFH) oder eine Antikoagulation [13]. [34]. Für den weiteren stationären Verlauf kann sich das generelle Management an Empfehlungen für den ischämischen Schlaganfälle orientieren, insbesondere die Vermeidung von Fieber sowie Hyperglykämien scheint das Outcome zu verbessern [35,36].…”
Section: Antithrombotisches Managementunclassified
“…Antifibrinolytics, in particular tranexamic acid (TXA), significantly reduce aneurysm rebleeding rates, but unfortunately this has not led to an improvement in either mortality or functional outcomes. 30,31 The major society guidelines offer contradictory recommendations. 8,9 Further evidence from large, welldesigned RCTs is needed.…”
Section: Antifibrinolytic Therapymentioning
“…It is striking how similar they are to the above described Finnish collection 'Ylpp€ o's children' made by Anni M€ ullensiefen in Berlin after 1910, not in disagreement with the fact that the collection in Oslo was in use in 1916 as part of a well-known exhibition about childbirth and poverty 'Barselhjemsutstillingen'. This exhibition was initiated by Katti Anker M€ oller (1868-1945) 31 and visited many Norwegian cities in 1916-1917. The moulages in Oslo have been photographed and digitalized, 32 but there are no plans for restoring them.…”
Section: No-2 the National Medical Museum Oslomentioning